Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19 Genetic Variants | Zendy

Yi Lin | Zendy; Anxin Wang | Zendy; Jiejie Li | Zendy; Jinxi Lin | Zendy; David Wang | Zendy; Xia Meng | Zendy; Lixian Ou | Zendy; Weiqi Chen | Zendy; Xingquan Zhao | Zendy; Liping Liu | Zendy; Yilong Wang | Zendy; Yongjun Wang | Zendy

Open Access

Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19 Genetic Variants

Author(s) -

Yi Lin,

Anxin Wang,

Jiejie Li,

Jinxi Lin,

David Wang,

Xia Meng,

Lixian Ou,

Weiqi Chen,

Xingquan Zhao,

Liping Liu,

Yilong Wang,

Yongjun Wang

Publication year - 2017

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.016463

Subject(s) - medicine , clopidogrel , aspirin , cyp2c19 , stroke (engine) , hazard ratio , antiplatelet drug , glycemic , proportional hazards model , confidence interval , cardiology , mechanical engineering , cytochrome p450 , metabolism , insulin , engineering

Dysglycemia may influence the predictive value of CYP2C19 loss-of-function allele for clinical efficacy of antiplatelet drug, but the role of glycated albumin (GA) remains unclear in patients with stroke on antiplatelet drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research